ProSomnus, Inc. (OSAPQ)
Aug 6, 2024 - OSAPQ was delisted (reason: shares cancelled)
0.0140
+0.0004 (2.94%)
Last trade price
on Aug 5, 2024
ProSomnus Revenue
ProSomnus had revenue of $9.09M in the quarter ending June 30, 2024, with 31.12% growth. This brings the company's revenue in the last twelve months to $31.46M, up 33.69% year-over-year. In the year 2023, ProSomnus had annual revenue of $27.65M with 42.59% growth.
Revenue (ttm)
$31.46M
Revenue Growth
+33.69%
P/S Ratio
0.01
Revenue / Employee
$231,324
Employees
136
Market Cap
243.52K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 27.65M | 8.26M | 42.59% |
| Dec 31, 2022 | 19.39M | 5.32M | 37.79% |
| Dec 31, 2021 | 14.07M | 5.79M | 69.86% |
| Dec 31, 2020 | 8.29M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOSAPQ News
- 2 months ago - ProSomnus® Sleep Technologies Announces Record Revenues as it Emerges from Reorganization - GlobeNewsWire
- 5 months ago - ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society - GlobeNewsWire
- 5 months ago - ProSomnus Announces Strong First Quarter 2024 Revenue Growth - GlobeNewsWire
- 5 months ago - ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting - GlobeNewsWire
- 5 months ago - Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices - GlobeNewsWire